Evolent Health, Inc.
EVH
$9.19
-$0.80-8.01%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -6.71% | 10.24% | 30.09% | 37.65% | 44.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.71% | 10.24% | 30.09% | 37.65% | 44.25% |
| Cost of Revenue | -4.18% | 17.62% | 45.49% | 53.59% | 56.05% |
| Gross Profit | -17.79% | -18.25% | -20.22% | -11.01% | 8.32% |
| SG&A Expenses | -1.01% | -11.02% | -16.25% | -22.36% | -10.04% |
| Depreciation & Amortization | -12.51% | -8.67% | -4.09% | 4.47% | 23.37% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.25% | 12.22% | 32.73% | 36.83% | 41.95% |
| Operating Income | -125.39% | -116.55% | -103.69% | 204.66% | 557.41% |
| Income Before Tax | -39.50% | 16.40% | 68.86% | 47.02% | 46.75% |
| Income Tax Expenses | 94.49% | 97.54% | 98.42% | 79.69% | 82.49% |
| Earnings from Continuing Operations | -75.30% | 1.25% | 45.49% | 20.60% | -17.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -75.30% | 1.25% | 45.49% | 20.60% | -17.14% |
| EBIT | -125.39% | -116.55% | -103.69% | 204.66% | 557.41% |
| EBITDA | -20.73% | -3.99% | 0.22% | 25.78% | 82.42% |
| EPS Basic | -71.39% | 2.63% | 36.14% | 10.93% | -32.47% |
| Normalized Basic EPS | -597.35% | -2,980.26% | 68.95% | 103.36% | 112.62% |
| EPS Diluted | -71.39% | 2.63% | 36.14% | 10.94% | -32.00% |
| Normalized Diluted EPS | -597.35% | -2,980.26% | 68.95% | 103.36% | 112.79% |
| Average Basic Shares Outstanding | 1.41% | 1.91% | 3.10% | 6.06% | 9.79% |
| Average Diluted Shares Outstanding | 1.41% | 1.91% | 3.10% | 6.06% | 8.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.46% | 0.02% | -0.96% | -0.89% | -1.04% |